Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

IMMUNOVANT INC (IMVT)

199 + Investors. Track Smart Money conviction in IMVT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +12
Streak
2Q ▲
Buyers last Q
60%

Smart Money Signals — IMVT

Based on 188 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added IMVT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 86% of 3.0Y peak

86% of all-time peak
188 funds currently hold this stock — 86% of the 3.0-year high of 218 funds (reached 2023 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +6% more funds vs a year ago

fund count last 6Q
+10 new funds entered over the past year (+6% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction. The peak was reached in just 3 quarters from the low — a sharp move.
🟢

More buyers than sellers — 60% buying

118 buying80 selling
Last quarter: 118 funds were net buyers (40 opened a brand new position + 78 added to an existing one). Only 80 were sellers (52 trimmed + 28 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+10 vs last Q)

new funds entering per quarter
Funds opening a new IMVT position: 38 → 23 → 30 → 40. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

55% of holders stayed for 2+ years

■ 55% conviction (2yr+) ■ 25% medium ■ 20% new
104 out of 188 hedge funds have held IMVT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +72% but shares only +9% — price-driven

Value
+72%
Shares
+9%
Last quarter: the total dollar value of institutional holdings rose +72%, but actual share count only changed +9%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📈

Growing discovery — still being found

35 → 38 → 23 → 30 → 40 new funds/Q
New funds entering each quarter: 38 → 23 → 30 → 40. A growing number of institutions are discovering IMVT each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Deep conviction — 62% of holders stayed 2+ years

■ 62% veterans ■ 14% 1-2yr ■ 24% new
Of 199 current holders: 124 (62%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 40% AUM from top-100 funds

40% from top-100 AUM funds
30 of 188 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in IMVT. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
2.9
out of 10
Low Exit Risk
Exit risk score 2.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — IMVT

In 2025 Q4, 118 hedge funds were net buyers of IMVT (40 opened a new position, 78 added to an existing one), while 80 reduced or exited (52 trimmed, 28 sold completely) — a 60% buyer ratio, indicating clear institutional accumulation. Net buying has persisted for two consecutive quarters, a positive momentum signal. 40% of total institutional value in IMVT is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +12 funds (more new holders than closures). Total institutional holders: 188.

Hedge Fund Ownership: IMVT

How many hedge funds hold IMVT — quarterly history vs. share price
Quarterly hedge fund ownership of IMVT vs. share price

Market Analysis: IMVT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: IMVT

Healthcare Biotechnology

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

40 top-rated funds 7 high-conviction
Consensus
7.0
/ 10
breadth
×
Elite
3.7
/ 10
conviction
Hedge Fund Positioning: IMVT
2026 Q1 Stats Unlock in 7 days 199 + Investors

Track Smart Money conviction in IMVT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 199 187 6.42%
13F Shares 105M 96M 9.48%
Total Value $2.66B $1.55B 71.96%
New Positions 43 31 +12
Increased Positions 86 87 -1
Closed Positions 30 18 +12
Reduced Positions 69 54 +15
Total Calls 8 8 -
Total Puts 6 5 20.0%
PUT/CALL Ratio 0.75 0.62 Neutral

Statistics: IMVT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

199 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IMVT. Verified SEC 13F-HR filings.

Top 25 institutional holders of IMVT — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Alchemi Wealth, LLC 0.74% 54,016 $1.3M
2 PSP Research LLC 0.34% 19,200 $477K
3 Ellsworth Advisors, LLC 0.15% 32,280 $802K
4 GSA CAPITAL PARTNERS LLP 0.11% 72,820 $2K
5 Candriam S.C.A. 0.09% 680,372 $16.9M
6 Hennion & Walsh Asset Management, Inc. 0.08% 91,009 $2.3M
7 China Universal Asset Management Co., Ltd. 0.07% 37,718 $937K
8 AXQ CAPITAL, LP 0.07% 22,072 $548K
9 PROFUND ADVISORS LLC 0.06% 61,008 $1.5M
10 JENNISON ASSOCIATES LLC 0.05% 3,196,705 $79.4M
11 FNY Investment Advisers, LLC 0.05% 4,500 —
12 Aberdeen Group plc 0.05% 1,160,762 $28.8M
13 Covestor Ltd 0.04% 2,596 —
14 Erste Asset Management GmbH 0.03% 144,500 $3.4M
15 Connor, Clark & Lunn Investment Management Ltd. 0.03% 503,673 $12.5M
16 BANQUE PICTET & CIE SA 0.02% 88,660 $2.2M
17 AlphaQuest LLC 0.01% 9,326 $237K
18 E Fund Management Co., Ltd. 0.01% 17,715 $440K
19 Pictet Asset Management Holding SA 0.01% 472,381 $11.7M
20 Caitong International Asset Management Co., Ltd 0.01% 1,883 $47K
21 Assenagon Asset Management S.A. 0.01% 205,219 $5.1M
22 INTECH INVESTMENT MANAGEMENT LLC 0.01% 29,979 $745K
23 E Fund Management (Hong Kong) Co., Ltd. 0.01% 541 $13K
24 Quantbot Technologies LP 0.01% 5,359 $133K
25 VANGUARD PORTFOLIO MANAGEMENT LLC 0.00% 3,704,905 $92.0M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — IMMUNOVANT INC (IMVT)

What does the Smart Money Trend signal show for IMVT?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added IMVT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for IMVT?

More buyers than sellers — 60% buying: Last quarter: 118 funds were net buyers (40 opened a brand new position + 78 added to an existing one). Only 80 were sellers (52 trimmed + 28 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for IMVT holders?

Elite ownership — 40% AUM from top-100 funds: 30 of 188 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in IMVT. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held IMVT?

55% of holders stayed for 2+ years: 104 out of 188 hedge funds have held IMVT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.